Literature DB >> 9397244

Myocardial wall thickness and left ventricular geometry in hypertensives. Relationship with insulin.

G Paolisso1, M Galderisi, M R Tagliamonte, M de Divitis, D Galzerano, A Petrocelli, P Gualdiero, O de Divitis, M Varricchio.   

Abstract

In hypertensive patients the presence of left ventricular (LV) hypertrophy has been associated with a more severe degree of insulin resistance. Whether myocardial wall thickness or LV geometry are associated with a different degree of insulin resistance is still unknown in essential hypertensives. For this reason 26 men with new diagnosed essential hypertension were enrolled. All patients underwent echocardiographic examination and euglycemic hyperinsulinemic glucose clamp combined with indirect calorimetry. According to LV mass and relative wall thickness data, all patients were categorized in four groups: 1) patients with a normal geometric LV pattern (n = 8) (PAT = 0); 2) patients with concentric remodeling LV mass (n = 8) (PAT = 1); 3) patients with eccentric LV hypertrophy (n = 3) (PAT = 2); and 4) patients with concentric LV hypertrophy (n = 7) (PAT = 3). All groups were similar for anthropometric characteristics. Patients with normal echocardiographic LV pattern (PAT = 0) had higher whole body glucose disposal (WBGD), oxidative and nonoxidative glucose metabolism, and lower lipid oxidation than patients with abnormal echocardiographic LV patterns (PAT = 1 to 3). Nevertheless, no significant differences among the groups with abnormal echocardiographic patterns were found. After controlling for age, body mass index (BMI), waist/hip ratio (WHR), and mean arterial blood pressure, only sum of the wall thickness was significantly correlated with fasting plasma insulin (r = -0.38, P < .05), WBGD (r = - 0.50, P < .009), and NOGM (r = - 0.48, P < .02). In multivariate analysis, a model made by age, BMI, WHR, systolic and diastolic blood pressure, and WBGD explained 38% of the echocardiographic pattern variability. In this model, WBGD (P < .02) was significantly and independently associated with echocardiographic patterns explaining 19% of the echocardiographic pattern variability. In conclusion, our data demonstrate that in arterial hypertension hyperinsulinemia/insulin resistance mainly affects myocardial wall thickness, whereas only a trivial association with LV geometry occurs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9397244     DOI: 10.1016/s0895-7061(97)00262-8

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  7 in total

1.  ACE gene polymorphism and cardiac structure in patients with insulin resistance.

Authors:  Fulya Akin; Sebahat Turgut; Dursun Dursunoglu; Gunfer Turgut; Ugur Karasu; Sukru Gur
Journal:  Mol Biol Rep       Date:  2008-03-18       Impact factor: 2.316

2.  The TRIB3 R84 variant is associated with increased left ventricular mass in a sample of 2426 White individuals.

Authors:  Gaia Chiara Mannino; Carolina Averta; Teresa Vanessa Fiorentino; Elena Succurro; Rosangela Spiga; Elettra Mancuso; Sofia Miceli; Maria Perticone; Angela Sciacqua; Francesco Andreozzi; Giorgio Sesti
Journal:  Cardiovasc Diabetol       Date:  2021-05-29       Impact factor: 9.951

3.  The Effect of Metabolic Syndrome on Myocardial Contractile Reserve during Exercise in Non-Diabetic Hypertensive Subjects.

Authors:  Tae Hoon Ha; Hye-Sun Seo; Woo Jin Choo; Jaehuk Choi; Jon Suh; Youn-Haeng Cho; Nae-Hee Lee
Journal:  J Cardiovasc Ultrasound       Date:  2011-12-27

4.  Insulin resistance and plasma triglyceride level are differently related to cardiac hypertrophy and arterial stiffening in hypertensive subjects.

Authors:  Liliana Legedz; Giampiero Bricca; Pierre Lantelme; Marie-Odile Rial; Pierre Champomier; Madeleine Vincent; Hugues Milon
Journal:  Vasc Health Risk Manag       Date:  2006

Review 5.  Differential Role of Leptin and Adiponectin in Cardiovascular System.

Authors:  C M Ghantous; Z Azrak; S Hanache; W Abou-Kheir; A Zeidan
Journal:  Int J Endocrinol       Date:  2015-05-03       Impact factor: 3.257

6.  Body mass index, type 2 diabetes, and left ventricular function.

Authors:  Katrine Dina Musaeus; Manan Pareek
Journal:  Cardiovasc Diabetol       Date:  2018-01-04       Impact factor: 9.951

7.  Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study.

Authors:  Mette Lundgren Nielsen; Manan Pareek; Oke Gerke; Margrét Leósdóttir; Peter M Nilsson; Michael Hecht Olsen
Journal:  BMC Cardiovasc Disord       Date:  2015-12-10       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.